Empower Advisory Group LLC Sells 32 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Empower Advisory Group LLC cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 1,665 shares of the medical equipment provider’s stock after selling 32 shares during the period. Empower Advisory Group LLC’s holdings in Intuitive Surgical were worth $869,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of ISRG. Howard Capital Management Group LLC increased its position in shares of Intuitive Surgical by 4.5% during the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after purchasing an additional 92 shares during the last quarter. Capital Investment Advisors LLC increased its position in shares of Intuitive Surgical by 7.3% during the 3rd quarter. Capital Investment Advisors LLC now owns 778 shares of the medical equipment provider’s stock valued at $382,000 after purchasing an additional 53 shares during the last quarter. Commonwealth Equity Services LLC increased its position in shares of Intuitive Surgical by 3.6% during the 3rd quarter. Commonwealth Equity Services LLC now owns 69,995 shares of the medical equipment provider’s stock valued at $34,386,000 after purchasing an additional 2,456 shares during the last quarter. Vest Financial LLC increased its position in shares of Intuitive Surgical by 202.4% during the 3rd quarter. Vest Financial LLC now owns 2,232 shares of the medical equipment provider’s stock valued at $1,097,000 after purchasing an additional 1,494 shares during the last quarter. Finally, Godsey & Gibb Inc. increased its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the transaction, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. This trade represents a 7.58 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now directly owns 353 shares of the company’s stock, valued at approximately $208,181.75. This trade represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock worth $3,587,582 in the last quarter. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Stock Up 0.9 %

ISRG opened at $601.17 on Wednesday. The stock has a market cap of $214.12 billion, a PE ratio of 93.79, a PEG ratio of 5.67 and a beta of 1.39. The business has a 50 day moving average of $560.61 and a 200-day moving average of $521.21. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Evercore ISI raised their price target on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Truist Financial raised their price target on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Finally, Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.